ARTICLE | Clinical News
Synthetic retrotransposon vectors regulatory update
September 17, 2001 7:00 AM UTC
Nature Technology received U.S. Patent No. 6,287,863 covering its VL30 retrotransposon vector for delivery and expression of transgenes. Nature Technology said the patent also covers the production of...